![Daniel Rankin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Rankin
Corporate Officer/Principal bei
SWEDISH ORPHAN BIOVITRUM AB
Vermögen: 684 445 $ am 30.06.2026
Profil
Daniel Rankin currently works at Swedish Orphan Biovitrum AB, as Head-Strategy & Corporate Development.
Dr. Rankin received his graduate degree from the University of Leiden, doctorate degree from the University of Helsinki, and undergraduate degree from the University of York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 14.338 ( 0 % ) | 684 445 $ | 30.06.2026 |
Aktive Positionen von Daniel Rankin
| Unternehmen | Position | Beginn |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Daniel Rankin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
 University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
University of York
 University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
